Inhibitor incidence in previously untreated patients with severe haemophilia B: a systematic literature review
- 1 January 2016
- journal article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 116 (07), 201-203
- https://doi.org/10.1160/th16-02-0116
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Toward optimal therapy for inhibitors in hemophiliaBlood, 2014
- FEIBA versus NovoSeven in Hemophilia Patients with InhibitorsSeminars in Thrombosis and Hemostasis, 2013
- Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition)British Journal of Haematology, 2012
- European Study on Orthopaedic Status of haemophilia patients with inhibitorsHaemophilia, 2007
- Inhibitor development in haemophilia B: an orphan disease in need of attentionBritish Journal of Haematology, 2007
- Inhibitor Development in Hemophiliacs: The Roles of Genetic versus Environmental FactorsSeminars in Thrombosis and Hemostasis, 2006
- Inhibitors in congenital coagulation disordersBritish Journal of Haematology, 2004
- Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study GroupBlood, 2003
- The epidemiology of inhibitors in haemophilia A: a systematic reviewHaemophilia, 2003
- Incidence of Factor IX Inhibitor Development in Severe Haemophilia B Patients Treated with only one Brand of High Purity Plasma Derived Factor IX ConcentrateThrombosis and Haemostasis, 1999